Cost-effectiveness of rotator cuff repair based on modern constructs, tear size, and implant cost at 1, 5, and 10 years

Q2 Medicine
Lambert T. Li MD , Krishna Mandalia BS , Andrew R. Ames DO , Stephen Le Breton BS , Albert Mousad BS , Katharine Ives BS , Janine Molino PhD , Sarav S. Shah MD
{"title":"Cost-effectiveness of rotator cuff repair based on modern constructs, tear size, and implant cost at 1, 5, and 10 years","authors":"Lambert T. Li MD ,&nbsp;Krishna Mandalia BS ,&nbsp;Andrew R. Ames DO ,&nbsp;Stephen Le Breton BS ,&nbsp;Albert Mousad BS ,&nbsp;Katharine Ives BS ,&nbsp;Janine Molino PhD ,&nbsp;Sarav S. Shah MD","doi":"10.1016/j.jseint.2025.04.038","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>To evaluate the cost-effectiveness of arthroscopic rotator cuff repair (RCR) utilizing multiple surgical constructs sorted by tear size.</div></div><div><h3>Methods</h3><div>Real-world cost data and previously published data on both anchor failure loads and retear rates by tear size and construct were inputted into a Markov model with time-points of 1, five, and ten years. Cost-effectiveness was assessed in terms of cost per quality-adjusted life-year (QALY). Health states included intact repair, asymptomatic or symptomatic retear, revision RCR, and cuff tear arthropathy. Knotted and knotless single row (SR) and double row (DR) constructs were used.</div></div><div><h3>Results</h3><div>For small and medium-sized tears, the optimal 10-year strategy was the DR knotted Corkscrew Biocomposite/Swivelock Biocomposite, which had an incremental cost-effectiveness ratio (ICER) of $12,562/QALY and $16,678/QALY, adding 0.54 QALY and 0.51 QALY versus nonoperative management, respectively. For large tears, the optimal 10-year strategy was the DR knotless Swivelock Biocomposite, which had an ICER of $19,836/QALY and added 0.53 QALY versus nonoperative management. For massive tears, the optimal 10-year strategy was the DR knotless Healicoil PEEK/Footprint Ultra polyether ether ketone, which had an ICER of $27,748/QALY and added 0.46 QALY versus nonoperative management.</div></div><div><h3>Conclusion</h3><div>Our study uniquely used modern suture anchors and construct configurations including knotted and knotless for multiple commercially available systems and for every tear size to evaluate short- and long-term cost-effectiveness. We found that, compared to nonoperative management, operative management of cuff tears was the optimal long-term treatment modality; specifically, when considering massive RCT, the DR knotless construct was optimal. This was supported by our finding that operative management of cuff tears is increasingly cost-effective with time, given nonrepaired cuff tears are unlikely to heal and portend worse symptomatology. Our findings may help inform surgeons/payors and guide anchor and construct selection for optimization of value-based care when performing arthroscopic RCR.</div></div>","PeriodicalId":34444,"journal":{"name":"JSES International","volume":"9 5","pages":"Pages 1524-1531"},"PeriodicalIF":0.0000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JSES International","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666638325001720","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background

To evaluate the cost-effectiveness of arthroscopic rotator cuff repair (RCR) utilizing multiple surgical constructs sorted by tear size.

Methods

Real-world cost data and previously published data on both anchor failure loads and retear rates by tear size and construct were inputted into a Markov model with time-points of 1, five, and ten years. Cost-effectiveness was assessed in terms of cost per quality-adjusted life-year (QALY). Health states included intact repair, asymptomatic or symptomatic retear, revision RCR, and cuff tear arthropathy. Knotted and knotless single row (SR) and double row (DR) constructs were used.

Results

For small and medium-sized tears, the optimal 10-year strategy was the DR knotted Corkscrew Biocomposite/Swivelock Biocomposite, which had an incremental cost-effectiveness ratio (ICER) of $12,562/QALY and $16,678/QALY, adding 0.54 QALY and 0.51 QALY versus nonoperative management, respectively. For large tears, the optimal 10-year strategy was the DR knotless Swivelock Biocomposite, which had an ICER of $19,836/QALY and added 0.53 QALY versus nonoperative management. For massive tears, the optimal 10-year strategy was the DR knotless Healicoil PEEK/Footprint Ultra polyether ether ketone, which had an ICER of $27,748/QALY and added 0.46 QALY versus nonoperative management.

Conclusion

Our study uniquely used modern suture anchors and construct configurations including knotted and knotless for multiple commercially available systems and for every tear size to evaluate short- and long-term cost-effectiveness. We found that, compared to nonoperative management, operative management of cuff tears was the optimal long-term treatment modality; specifically, when considering massive RCT, the DR knotless construct was optimal. This was supported by our finding that operative management of cuff tears is increasingly cost-effective with time, given nonrepaired cuff tears are unlikely to heal and portend worse symptomatology. Our findings may help inform surgeons/payors and guide anchor and construct selection for optimization of value-based care when performing arthroscopic RCR.
基于现代构造、撕裂大小和1年、5年和10年种植体成本的肩袖修复的成本-效果
研究背景:评估关节镜下肩袖修复术(RCR)的成本-效果。方法将实际成本数据和之前公布的锚破坏载荷和撕裂大小和结构的再撕裂率数据输入到一个时间点为1年、5年和10年的马尔可夫模型中。成本效益是根据每个质量调整生命年(QALY)的成本来评估的。健康状态包括完整修复、无症状或症状性撕裂、修复RCR和袖带撕裂关节病。采用有结和无结单排(SR)和双排(DR)结构。结果对于中小型撕裂,最佳的10年策略是DR knot Corkscrew Biocomposite/Swivelock Biocomposite,其增量成本-效果比(ICER)分别为$12,562/QALY和$16,678/QALY,与非手术治疗相比分别增加了0.54和0.51 QALY。对于大撕裂,最佳的10年策略是DR无结Swivelock生物复合材料,ICER为19,836美元/QALY,与非手术治疗相比,QALY增加了0.53美元。对于大面积撕裂,10年最佳策略是DR无结Healicoil PEEK/Footprint Ultra聚醚醚酮,ICER为27,748美元/QALY,与非手术治疗相比,QALY增加了0.46美元。我们的研究独特地使用了现代缝合锚,并构建了包括有结和无结的结构,用于多种市售系统和各种撕裂大小,以评估短期和长期的成本效益。我们发现,与非手术治疗相比,手术治疗袖带撕裂是最佳的长期治疗方式;具体而言,当考虑大规模RCT时,DR无结结构是最佳的。我们的研究结果支持了这一点,即随着时间的推移,手术治疗袖带撕裂的成本效益越来越高,因为未修复的袖带撕裂不太可能愈合,并预示着更严重的症状。我们的研究结果可能有助于告知外科医生/付款人,并指导锚和结构的选择,以便在进行关节镜下RCR时优化基于价值的护理。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
JSES International
JSES International Medicine-Surgery
CiteScore
2.80
自引率
0.00%
发文量
174
审稿时长
14 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信